Escitalopram in treatment of post-stroke depression;İnme sonrasi depresyon tedavisinde essitalopram

Klinik Psikofarmakoloji Bulteni

Volumn 20, Issue 1, 2010, Pages 74-78

  Havle, Nedim ^a   Altunkaynak, Yavuz ^b   Dayan, Cengiz ^b   Ilnem, M Cem ^a   Arpaci, Baki ^b  

^a Bakirkoy Ruh Sagligi ve Sinir Hastaliklari Egitim ve Arastirma Hastanesi   (Turkey)

^b Nöroloji Uzmani ^*  (Turkey)

Author keywords

Depression; Escitalopram; Hamilton depression scale; Stroke

Indexed keywords

ESCITALOPRAM; PLACEBO;

AGE DISTRIBUTION; AGED; ANXIETY DISORDER; ARTICLE; BARTHEL INDEX; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE SEVERITY; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; DYSPEPSIA; FEMALE; FUNCTIONAL DISEASE; HAMILTON SCALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NAUSEA; PANIC; PHYSICAL ACTIVITY; POSTSTROKE DEPRESSION; RANKIN SCALE; RATING SCALE; SCORING SYSTEM; SEX RATIO; SMOKING; STROKE; SYMPTOM;

EID: 77957157961     PISSN: 10177833     EISSN: 13029657     Source Type: Journal    
DOI: 10.1080/10177833.2010.11790637     Document Type: Article

References (22)

1. Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: a systematic review of observational studies. Stroke 2005; 36: 1330-1340. (Pubitemid 40798764)
2. Astrom M, Adolfsson R, Asplund K. Major depression in stroke patients. A 3-year longitudinal study. Stroke 1993; 24: 976-982.
3. Kotila M, Numminen H, Waltimo O, Kaste M. Post-stroke depression and functional recovery in a population-based stroke register. The Finnstroke study. Eur J Neurol 1999; 6: 309-312. (Pubitemid 29250990)
4. Morris PL, Robinson RG, Andrzejewski P, Samuels J, Price TR. Association of depression with 10-year poststroke mortality. Am J Psychiatry 1993; 150: 124-129. (Pubitemid 23059176)
5. Khan F. Poststroke depression. Aust Fam Physician 2004; 33: 831-834.
6. Hoschl C, Svestka J. Escitalopram for the treatment of major depression and anxiety disorders. Expert Rev Neurother 2008; 8: 537-552. (Pubitemid 351551007)
7. Akdemir A, Örsel S, Daǧ İ, Türkçapar H, İscan N, Özbay H. Hamilton Depresyon Derecelendirme Ölçeǧi (HDDÖ)'nin geçerliǧi, güvenirliǧi ve klinikte kullanimi. Psikiyatri Psikoloji Psikofarmakoloji Dergisi 1996; 4: 251-259.
8. Güngen C, Ertan T, Eker E, Yaşar R, Engin F. Standardize Mini Mental Test'in Türk toplumunda hafif demans tanisinda geçerlik ve güvenilirliǧi. Türk Psikiyatri Dergisi 2002; 13: 273-281.
9. Hadidi N, Treat-Jacobson DJ, Lindquist R. Poststroke depression and functional outcome: a critical review of literature. Heart Lung 2009; 38: 151-162.
10. Bilge C, Kocer E, Kocer A, Turk Boru U. Depression and functional outcome after stroke: the effect of antidepressant therapy on functional recovery. Eur J Phys Rehabil Med 2008; 44: 13-18.
11. Gainotti G, Antonucci G, Marra C, Paolucci S. Relation between depression after stroke, antidepressant therapy, and functional recovery. J Neurol Neurosurg Psychiatry 2001; 71: 258-261. (Pubitemid 32675158)
12. Bhogal SK, Teasell R, Foley N, Speechley M. Heterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of poststroke depression. J Am Geriatr Soc 2005; 53: 1051-1057. (Pubitemid 41647607)
13. Hackett ML, Anderson CS, House AO. Management of depression after stroke: a systematic review of pharmacological therapies. Stroke 2005; 36: 1098-1103.
14. Chen Y, Guo JJ, Zhan S, Patel NC. Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis. Ann Pharmacother 2006; 40: 2115-2122. (Pubitemid 44954428)
15. Robinson RG, Schultz SK, Castillo C, Kopel T, Kosier JT, Newman RM, Curdue K, Petracca G, Starkstein SE. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry 2000; 157: 351-359.
16. Cipriani A, Santilli C, Furukawa TA, Signoretti A, Nakagawa A, McGuire H, Churchill R, Barbui C. Escitalopram versus other antidepressive agents for depression. Cochrane Database Syst Rev 2009: CD006532.
17. Wu E, Greenberg P, Yang E, Yu A, Ben-Hamadi R, Erder MH. Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants. Curr Med Res Opin 2008; 24: 2805-2813.
18. Robinson RG, Jorge RE, Moser DJ, Acion L, Solodkin A, Small SL, Fonzetti P, Hegel M, Arndt S. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008; 299: 2391-2400.
19. Andersen G, Vestergaard K, Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994; 25: 1099-1104. (Pubitemid 24164745)
20. The National Institute of Neurological Disorders and Stroke rt-PA stroke study group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 335: 1581-1587
21. Wade DT. Measurement in Neurological Rehabilitation. Handicap and Quality of Life. Oxford University. 1992; 89-96.
22. Martin S Denis.Long Term Survival After First Ever Stroke The Oxfordshire Community Stroke Project. Stroke 1993; 24(6): 796-800.